Ranflox 500 Tablet

RANFLOX® 500 Tablet: Each film coated tablet contains Ciprofloxacin Hydrochloride BP equivalent to 500 mg Ciprofloxacin.

RANFLOX® 750 Tablet: Each film coated tablet contains Ciprofloxacin Hydrochloride BP equivalent to 750 mg Ciprofloxacin.

Ciprofloxacin is indicated for the treatment of single infection or mixed infections caused by two or more susceptible organisms. Ciprofloxacin can also be used for infections caused by organisms resistant to other antibiotics including aminoglycosides, penicillins and cephalosporins. The extensive tissue penetration of Ciprofloxacin combined with its enhanced antibacterial activity (including antipseudomonal activity), enables Ciprofloxacin to be used alone (depending on sensitivity results) or in combination with an aminoglycoside or with beta-lactam antibiotics, for instance, when severe neutropenia is present or with an antibiotic active against anaerobes where the presence of Bacteroides fragilis is suspected. Ciprofloxacin is indicated for the treatment of the following infections caused by sensitive bacteria: Severe systemic infections: Septicaemia, bacteremia, peritonitis, and infections in immunosuppressed patients with hematological or solid tumors and in patients in intensive care with specific problems such as infected burns. Respiratory tract infections: Lobar and bronchopneumonia, acute, and chronic bronchitis, acute exacerbation of cystic fibrosis, bronchiectasis, empyema. Urinary tract infections: Uncomplicated and complicated urethritis, cystitis, pyelonephritis, prostatitis, epididymitis. Skin and soft tissue infections: Infected ulcers, wound infections, abscesses, cellulitis, otitis externa, erysipelas, and infected burns. Gastro-intestinal infections: Enteric fever, infective diarrhoea. Infections of the biliary tract: Cholangitis, cholecystitis, empyema of the gall bladder. Intra-abdominal infections: Peritonitis, intra-abdominal abscesses. Bone and joint infections: Osteomyelitis, septic arthritis. Pelvic infections: Salpingitis, endometritis, and pelvic inflammatory diseases. Eye, ear, nose and throat infections: Otitis media, sinusitis, mastoiditis, and tonsillitis. Gonorrhoea : Urethral, rectal and pharyngeal gonorrhoea caused by beta-lactamase producing organisms or organisms moderately sensitive to penicillins.

General dosage recommendations: The dosage of Ciprofloxacinis determined by the sensitivity of the causative organism(s) and the age, weight and renal function of the patient. Adults: The dosage range for adults is 250-750 mg twice daily.